Leonard S. Jacob - Aug 27, 2021 Form 4 Insider Report for ANTARES PHARMA, INC. (ATRS)

Role
Director
Signature
/s/ Lisa M. Kallebo as attorney-in-fact for Leonard S. Jacob
Stock symbol
ATRS
Transactions as of
Aug 27, 2021
Transactions value $
$1
Form type
4
Date filed
8/31/2021, 06:26 PM
Previous filing
Jun 14, 2021
Next filing
Feb 4, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ATRS Common Stock Award $55.3K +24.7K +8.67% $2.24 309K Aug 27, 2021 Direct
transaction ATRS Common Stock Tax liability -$55.3K -13.8K -4.47% $4.00 296K Aug 27, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ATRS Stock Option (right to buy) Options Exercise $0 +24.7K $0.00* 0 Aug 27, 2021 Common Stock 24.7K $2.24 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares withheld by the company to cover the exercise price for the underlying stock option exercise. No shares were actually sold.
F2 The options vested and became exercisable one year from the grant date of September 9, 2011. The stock options were due to expire on September 8, 2021.